Advanced Therapies

Mechanism

Related News

CGT Catapult establishes Technology Advisory Board for advanced therapy deployment

May 20, 2026

Cell and Gene Therapy Catapult has established a Technology Advisory Board to support technology deployment across advanced therapies. The board will focus on data, manufacturing, testing and patient pathways.

Origin Genomics Launches Amid Germline Editing Controversy; Thermo Fisher Completes $8.88B Clario Acquisition

Mar 27, 2026

Origin Genomics launches to pursue germline gene editing research despite US prohibitions, while Thermo Fisher completes its $8.88 billion acquisition of Clario Holdings. Lucid Diagnostics reports Q4 revenue growth, and multiple partnerships form across the diagnostics and synthetic biology sectors.